Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two va…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib [Phase 3]
Phase 3 booster study evaluating immunogenicity, reactogenicity, and safety of GSK's DTPw-HBV/Hib vaccine booster compared with the standard…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 [Phase 2]
Phase 2 clinical trial update evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine and a single dose of t…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth [Phase 3]
This Phase 3 trial evaluated and compared the immune responses to two DTP-containing vaccines (Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hi…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]
A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants [Phase 3]
This Phase 3 trial in healthy infants evaluated whether giving Tritanrix-HepB/Hib-MenAC with a birth-dose Hepatitis B vaccine yields an immu…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety [Phase 2]
Phase 2 trial comparing GSK's DTaP-IPV candidate vaccine with separately administered DTaP and IPV vaccines to assess immune response and sa…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. [Phase 3]
Phase 3 results evaluating a GSK Tdap booster vaccine candidate for immunogenicity and safety in children and adolescents previously given f…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) [Phase 4]
Phase 4 immunogenicity and reactogenicity study of Boostrix and Boostrix-IPV has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. [Phase 2]
Phase 2 trial by GlaxoSmithKline evaluated antibody persistence and booster response, as well as safety, in individuals previously primed wi…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine [Phase 3]
Phase 3 trial comparing a combined Tdap booster to a licensed Td vaccine has completed, assessing protection against diphtheria, tetanus, an…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® [Phase 3]
Phase 3 trial comparing GlaxoSmithKline's reduced antigen DTaP-IPV vaccine to Boostrix and standalone or Revaxis-administered IPV in tetanus…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. [Phase 4]
This Phase 4 trial update evaluates immunogenicity, antibody persistence, and safety of GSK's DTPa INFANRIX and dTpa BOOSTRIX vaccines; the …
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Seroepidemiological Study of Pertussis and Other Infectious Diseases
Completed seroepidemiological study of pertussis and other infectious diseases. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
Completed descriptive post-marketing safety study of the ADACEL vaccine (Tdap) monitoring adverse events under passive surveillance for pert…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Study of Adacel® Vaccine Administered to Persons 10 Years of Age [Phase 4]
Phase 4 clinical trial of the Adacel vaccine in 10-year-olds with results posted, evaluating safety and immunogenicity against tetanus, diph…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice [NA]
A completed clinical trial evaluating how the clinical tool 'What’s Going Around' influences practice for influenza-like illness, asthma, Gr…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) [Phase 1]
Phase 1 persistency study of aP/Tdap booster vaccines in adults completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Protecting Pregnant Women From Infectious Diseases [NA]
Completed clinical trial update from Emory University on protecting pregnant women from influenza and pertussis.